Omega Bio-Tek

Omega Bio-Tek

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $20M

Overview

Omega Bio-tek is a established, privately-held provider of nucleic acid purification technologies, operating in the diagnostics and life science research tools sector. The company has built a strong reputation over 25 years for product reliability and customer partnership, with its kits being utilized by prominent institutions like the University of Oxford and diagnostic labs such as Myriad Genetics and Gravity Diagnostics. Its business model centers on selling consumable kits and providing custom automation services, positioning it as a key enabler in genomics workflows without developing its own therapeutic or diagnostic tests. The company appears to be revenue-generating, supported by a diverse customer base and a portfolio focused on extraction efficiency and workflow integration.

Diagnostics

Technology Platform

Magnetic bead-based nucleic acid (DNA/RNA) purification chemistry and custom automated workflow integration services for liquid handling platforms.

Funding History

2
Total raised:$20M
Series B$12M
Series A$8M

Opportunities

The growing global demand for genomic analysis in research, clinical diagnostics, and applied markets drives continuous need for reliable nucleic acid purification.
The trend toward laboratory automation presents a major opportunity to expand high-margin custom workflow integration services.
Emerging fields like mRNA therapeutics and liquid biopsy (cfDNA) create new application areas for specialized extraction kits.

Risk Factors

Faces intense competition from larger, well-established players like Qiagen and Thermo Fisher Scientific.
Reliance on a stable supply chain for raw materials poses operational risks.
As a private company, it may have more limited capital for aggressive expansion or R&D compared to public competitors.

Competitive Landscape

Omega Bio-tek competes in the crowded nucleic acid purification market against dominant multinational corporations (Qiagen, Thermo Fisher, Promega) and numerous smaller specialists. It differentiates through a strong focus on customer partnership, customization for automated workflows, and high-touch technical support, rather than competing solely on breadth of catalog or lowest price.